The revolution in the speed, reliability and cost of human genome sequencing will spread into doctors’ offices next year, predicts Cliff Reid, chairman, president and CEO of Complete Genomics. But just a few years ago, that dream was shrouded by the day-to-day realities of trying to keep the Mountain View company afloat.
No comments:
Post a Comment